{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T20:10:20Z","timestamp":1651435820719},"reference-count":7,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.710","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T22:07:41Z","timestamp":1425938861000},"page":"710-716","source":"Crossref","is-referenced-by-count":1,"title":["6. Metabolic Syndrome and Chronic Kidney Disease"],"prefix":"10.2169","volume":"103","author":[{"given":"Hiroshi","family":"Itoh","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"3) Nakaya H, et al: Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 12 (4): 659-666, 2001.","DOI":"10.1681\/ASN.V124659"},{"key":"2","doi-asserted-by":"crossref","unstructured":"4) Ishiguro K, et al: "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension. Hypertension 53 (1): 83-89, 2009. doi: 10.1161\/HYPERTENSIONAHA.108.122721. Epub 2008 Dec 1.","DOI":"10.1161\/HYPERTENSIONAHA.108.122721"},{"key":"3","doi-asserted-by":"crossref","unstructured":"5) Hasegawa K, et al: Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 19 (11): 1496-1504, 2013. doi: 10.1038\/nm.3363. Epub 2013 Oct 20.","DOI":"10.1038\/nm.3363"},{"key":"4","doi-asserted-by":"crossref","unstructured":"6) Hasegawa K, et al: The hydrolase DDAH2 enhances pancreatic insulin secretion by transcriptional regulation of secretagogin through a Sirt1-dependent mechanism in mice. FASEB J 27 (6): 2301-2315, 2013. doi: 10.1096\/fj.12-226092. Epub 2013 Feb 21.","DOI":"10.1096\/fj.12-226092"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7) Hayashi K, et al: Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int 78 (1): 69-78, 2010. doi: 10.1038\/ki.2010.81. Epub 2010 Apr 7.","DOI":"10.1038\/ki.2010.81"},{"key":"6","doi-asserted-by":"crossref","unstructured":"8) Julius S, et al; Trial of Preventing Hypertension (TROPHY) Study Investigators: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354 (16): 1685-1697, 2006. Epub 2006 Mar 14.","DOI":"10.1056\/NEJMoa060838"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9) Sasamura H, et al; STAR CAST investigators: Feasibility of regression of hypertension using contemporary antihypertensive agents. Am J Hypertens 26 (12): 1381-1388, 2013. doi: 10.1093\/ajh\/hpt105.","DOI":"10.1093\/ajh\/hpt105"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["6\uff0e\u30e1\u30bf\u30dc\u30ea\u30c3\u30af\u30b7\u30f3\u30c9\u30ed\u30fc\u30e0\u3068\u6162\u6027\u814e\u81d3\u75c5\uff08CKD\uff09"],"language":"en","deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T19:30:18Z","timestamp":1651433418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/3\/103_710\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.710","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}